Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 28, 2020
PharmaMar and Bionical Emas have announced the launch of an EAP for lurbinectedin to treat patients in the United States with relapsed SCLC, who are unable to enter clinical trials and there are no appropriate alternative treatments.
read more
Thursday, January 23, 2020
Catalent supports the news that DiaMedica received FDA approval to commence Phase 2 clinical trials of DM199 for chronic kidney disease.
read more
Thursday, January 23, 2020
Genome & Company has entered into a clinical trial collaboration and supply agreement with Merck KGaA and Pfizer to evaluate GEN-001 therapy in combination with avelumab.
read more
Wednesday, January 22, 2020
Civica Rx has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
read more
Tuesday, January 21, 2020
Cipher announced the Company received a Notice of Termination from Bausch Health in connection with the License, Development and Commercialization Agreement of Trulance.
read more
Wednesday, January 15, 2020
Dermavant Sciences has entered into a collaboration and license agreement with Japan Tobacco for exclusive rights to develop, register and market tapinarof in Japan for psoriasis and atopic dermatitis.
read more
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more
Tuesday, January 14, 2020
Tauriga Sciences announced plans to commence development of a pharmaceutical grade version of Tauri-Gum.
read more
Wednesday, January 08, 2020
Alcami announced the sale of its preclinical and early stage active pharmaceutical ingredient facility in Weert, Netherlands to MercachemSyncom.
read more
Wednesday, January 08, 2020
Sirnaomics and Innovent Biologics announced they have entered a strategic collaboration to conduct clinical studies, using STP705 and Tyvyt.
read more
WuXi STA announced the opening of its large-scale oligonucleotide API manufacturing facility in Changzhou, China.
read more
Pulmatrix has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson.
read more
Thursday, January 02, 2020
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs has received FDA approval for their generic version of Febuxostat 40mg and 80mg tablets.
read more
Thursday, January 02, 2020
MediWound announced the signing of a distribution agreement granting Balance Medical the exclusive rights to market and distribute NexoBrid® in Australia, New Zealand and Singapore for the treatment of severe burns.
read more
Thursday, January 02, 2020
Arena Pharmaceuticals and Beacon Discovery have entered into a strategic multi-year partnership aimed at building novel medicines across a range of GPCR targets.
read more